ArticleCureus2025
Treatment of Prosthetic Vascular Graft Infections Using Cryopreserved Homografts: A Surgical Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infections of vascular prostheses remain a formidable challenge in vascular surgery due to their high morbidity and mortality rates. This retrospective study presents the clinical experience of using vascular homografts in four complex cases of infected synthetic vascular prostheses treated between 2015 and 2020. Patients presented with varied complications, including duodeno-paraprosthetic fistula, aneurysmal degeneration, thromboembolism, and infection following aorto-bifemoral and iliofemoral bypasses, as well as stent-graft infections. In all but one case, homograft reconstruction led to favorable outcomes, with long-term follow-up confirming graft patency and absence of reinfection. One patient succumbed to sepsis and multiorgan failure postoperatively. The use of cryopreserved homografts demonstrated efficacy and safety, particularly in cases unsuitable for synthetic or autologous grafts. Our findings highlight the potential of vascular homografts as a valuable alternative in managing prosthetic graft infections, emphasizing the importance of individualized treatment approaches, multidisciplinary planning, and advanced surgical techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.